# Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone

> **NCT02729376** · PHASE1 · COMPLETED · sponsor: **LTN PHARMACEUTICALS, INC.** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** galeterone

## Key facts

- **NCT ID:** NCT02729376
- **Lead sponsor:** LTN PHARMACEUTICALS, INC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729376, "Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02729376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*